Mouwasat Medical Services Company (TADAWUL:4002)
61.20
-2.70 (-4.23%)
Aug 13, 2026, 3:19 PM AST
TADAWUL:4002 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TADAWUL:4002 stock has a consensus rating of "Buy" and an average price target of SAR 85.25. The average 1-year stock price forecast is 39.30% higher than the current stock price, while the lowest is SAR 63.00 (+2.94%) and the highest is SAR 124.00 (+102.61%).
Price Target: SAR 85.25 (+39.30%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4002 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 6 | 6 | 6 |
| Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Hold | 6 | 5 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 0 | 0 | 0 |
| Total | 10 | 12 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
3.63B
from 3.22B
Increased by 12.78%
Revenue Next Year
3.99B
from 3.63B
Increased by 9.81%
EPS This Year
4.26
from 4.11
Increased by 3.69%
EPS Next Year
4.51
from 4.26
Increased by 5.83%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.